Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Half Moon Medical
AddedFeb 17, 2024
UpdatedJun 18, 2026
Half Moon Medical

Half Moon Medical

Pre-Seed

Half Moon Medical: Innovating transcatheter treatment devices to combat mitral regurgitation since 2017.

HQ
Menlo Park, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees

Half Moon Medical is a medical device company developing a novel transcatheter treatment device to reduce mitral regurgitation.

The company was founded in 2017 and is based in Menlo Park, California, United States.

Half Moon Medical - Similar Companies

Polares logo

Polares

polaresmedical.com

MitraSpan logo

MitraSpan

Tau-Pnu Medical logo

Tau-Pnu Medical

Opus Medical Therapies logo

Opus Medical Therapies

opus-medical.com

4C Medical Technologies logo

4C Medical Technologies

4cmed.com

Moray Medical logo

Moray Medical

moraymedical.com

Mvrx logo

Mvrx

East End Medical logo

East End Medical

Conformal Medical logo

Conformal Medical

Capstan Medical logo

Capstan Medical

capstanmedical.com

Cardiac Dimensions logo

Cardiac Dimensions

Nyra Medical logo

Nyra Medical

nyramed.com

Laplace Interventional logo

Laplace Interventional

laplaceint.com

EndoShunt Medical logo

EndoShunt Medical

endoshunt.com

Protaryx Medical logo

Protaryx Medical

protaryx.com

Half Moon Medical - Quick Facts

Who are Half Moon Medical's competitors?

Companies similar to Half Moon Medical include Polares, MitraSpan, Tau-Pnu Medical and Opus Medical Therapies.

When was Half Moon Medical founded?

Half Moon Medical was founded in 2017.

Where is Half Moon Medical's headquarters located?

Half Moon Medical's headquarters is located in Menlo Park, CA, US.

When was Half Moon Medical's last funding round?

Half Moon Medical's most recent funding round was for $1M (USD) in February 2023.

How much has Half Moon Medical raised to-date?

As of Feb 21, 2023, Half Moon Medical has raised a total of $3M (USD).

How many employees does Half Moon Medical have?

Half Moon Medical has 17 employees as of Feb 5, 2024.

Half Moon Medical - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
  • HealthTech
Geographic Exposure
  • United States
Revenue
  • Recurring
Main Product
  • Medical Devices
Tags
  • SaaS
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified